Double-blind, placebo-controlled trial of the efficacy and safety of azelastine hydrochloride in children with perennial allergic rhinitis
It is essential to perform studies in school children (6-11 years). However, for INAH, few studies exist in SAR, and, to our knowledge, there are no studies in PAR. This study shows for the first time that the higher dose of AZE is safe and effective in school children with PAR.
Authors
- Rajesh Kumar Ramalingam (ORCID: https://orcid.org/0000-0003-0690-1283)
- G. Walter Canonica
- Ludger Klimek (ORCID: https://orcid.org/0000-0002-2455-0192)
- Hans-Christian Kuhl
- Jean Bousquet (ORCID: https://orcid.org/0000-0002-4061-4766)
- Duc Tung Nguyen (ORCID: https://orcid.org/0000-0002-8954-3604)
- William E. Berger (ORCID: https://orcid.org/0000-0001-6019-129X)
Institutions
- Humanitas University (IT)
- Johannes Gutenberg University Mainz (DE)
- Humboldt-Universität zu Berlin (DE)
- California Allergy and Asthma Medical Group (US)
- Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE)
- Zentrum für Rhinologie und Allergologie (DE)
- Mylan (India) (IN)
- Meda (Germany) (DE)
- Tris Pharma (United States) (US)
- IRCCS Humanitas Research Hospital (IT)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1159/000542054
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00